← All decks

Radiology

Positron Emission Tomography

Built from Fundamentals of Diagnostic Radiology

What’s inside

9 sections · 149 slides

  1. 01

    Overview

    • What this topic covers

    1 slide

  2. 02

    How PET works

    Positron decay, annihilation photons, detectors, and hybrid systems

    • What positron emission tomography detects
    • Positron-emitting radionuclides
    • Positron travel and image sharpness
    • From positron to image
    • PET cameras and coincidence detection
    • Time-of-flight PET
    • Hybrid scanners: PET/CT
    • PET/MR
    • Attenuation and its correction
    • Reading corrected and uncorrected images

    10 slides

  3. 03

    Performing and interpreting PET/CT

    Patient preparation, acquisition, and FDG biology

    • Preparing the patient for FDG PET
    • Limiting bladder activity
    • How the scan is acquired
    • Contrast and PET
    • Interpreting a PET/CT
    • FDG: the workhorse tracer
    • How FDG is trapped in cells
    • What drives FDG accumulation
    • Normal and variant FDG activity

    9 slides

  4. 04

    Normal FDG distribution

    Organ-by-organ physiologic uptake

    • Skeletal muscle uptake
    • Whole-body FDG PET biodistribution
    • Physiologic FDG uptake in muscle
    • Brain uptake
    • Physiologic FDG uptake in the brain
    • Cardiac muscle uptake
    • Physiologic FDG uptake in the heart
    • Liver and gallbladder uptake
    • Physiologic FDG uptake in the liver
    • Spleen and bone marrow uptake
    • Stomach uptake
    • Colon uptake
    • Massive physiologic colon activity
    • Metformin and bowel activity
    • Urinary tract activity
    • Normal urinary tract FDG activity
    • Uterus and ovaries
    • Corpus luteum cyst on FDG PET
    • Salivary and thyroid glands
    • Brown fat
    • Brown fat hypermetabolism

    21 slides

  5. 05

    Standard uptake values (SUV)

    Semiquantifying tracer uptake

    • What the SUV measures
    • Interpreting SUV numbers

    2 slides

  6. 06

    Oncologic PET imaging

    Staging, response, and recurrence across tumor types

    • Three core oncology indications
    • Lung cancer overview
    • Solitary pulmonary nodule (SPN)
    • Hot pulmonary nodule: incidental carcinoma
    • Warm pulmonary nodule: bronchoalveolar carcinoma
    • SPN false results and SUV cutoff
    • Reading a solitary pulmonary nodule
    • Lung cancer staging
    • Lung cancer staging on PET/CT
    • Lung cancer recurrence and response
    • Postradiation pneumonitis
    • Lymphoma staging principles
    • Lymphoma staging
    • Lymphoma false results
    • Lymphoma initial staging
    • Splenic lymphoma
    • Lymphoma bone marrow
    • Lymphoma early treatment response
    • Lymphoma: early treatment response
    • Lymphoma posttherapy residual mass
    • Lymphoma recurrence
    • Melanoma
    • Melanoma recurrence
    • Esophageal cancer
    • Esophageal recurrence
    • Gastric cancer
    • Pancreatic cancer
    • Colorectal cancer staging
    • Colon cancer staging
    • Colorectal false positives and technique
    • Colorectal nodes and liver
    • Hepatic metastasis from colon cancer
    • Colorectal recurrence
    • Colon anastomosis activity
    • Hepatocellular carcinoma
    • Cholangiocarcinoma
    • Hepatic metastases
    • Necrotic hepatic metastasis
    • Gallbladder cancer
    • Cholecystitis on PET/CT
    • Breast cancer on PET
    • Breast cancer on PET/CT
    • Breast cancer limits and sentinel nodes
    • Lactational breast uptake
    • Breast PET technique
    • Axillary node metastasis in breast cancer
    • Internal mammary node metastases
    • Breast pitfalls
    • Cervical cancer
    • Uterine cancer
    • Uterine cancer recurrence
    • Ovarian cancer
    • Stage 1 ovarian cancer
    • Renal and bladder malignancies
    • Transitional cell carcinoma of the bladder
    • Adrenal lesions
    • Adrenal metastasis
    • Benign adrenal adenoma
    • Testicular cancer
    • Prostate cancer
    • Head and neck cancers
    • Squamous cell carcinoma of the tongue
    • Head and neck challenges
    • Metastatic nasopharyngeal carcinoma: axial views
    • Metastatic nasopharyngeal carcinoma: coronal views
    • Sarcomas and osseous malignancies
    • Facet joint inflammation, not metastasis
    • Bone marrow stimulation versus metastases
    • Benign hypermetabolic bone marrow
    • Diffuse metastases with hypermetabolic marrow
    • Hot and cold osseous metastases
    • Hot and cold osseous metastases
    • FDG-avid osseous metastasis
    • Neuroendocrine tumors
    • Somatostatin receptor avid metastases

    75 slides

  7. 07

    Infection and inflammation

    Fever of unknown origin and sarcoidosis

    • PET in inflammation and infection
    • Fever of unknown origin (FUO)
    • Sarcoidosis
    • Cardiac sarcoidosis

    4 slides

  8. 08

    Pitfalls in PET/CT

    Physiologic, inflammatory, and technical traps

    • The core pitfall: physiologic activity
    • Brown fat revisited
    • Inflammatory processes
    • Shoulder arthritis
    • Immunotherapy-related activity
    • Immunotherapy-associated colitis
    • Benign tumors and recent surgery
    • Fractures
    • Rib fracture on PET/CT
    • Low-uptake malignancies
    • Attenuation-correction artifacts
    • Misregistration
    • CT truncation and injection leakage
    • Thymic rebound
    • Thymic rebound
    • Osteophytes and medications

    16 slides

  9. 09

    Emerging tracers

    Beyond FDG: fluciclovine and PSMA

    • Limits of FDG
    • Fluciclovine (FACBC)
    • F-18 fluciclovine PET/CT
    • PSMA PET
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Brant and Helms' Fundamentals of Diagnostic Radiology

    11 slides